|
CHECK OUT OUR JULY ISSUE
Medications currently in development show promise in giving providers and patients more options to help maintain progression-free survival. » More
|
|
Specialty pharmaceuticals are continuing to play an increasingly large role in managed care plan budgets and are certainly deserving of the increased payer attention they are receiving, according to a recent trend report. » More
|
|
Investigators determined that the Age-Related Eye Disease Study formulation slowed the progression of advanced age-related macular degeneration with a 25% decrease in the likelihood of progression to advanced AMD compared with a placebo. » More
|
|
Health insurers and payers are increasingly using utilization management programs to encourage safe and cost-effective medication use. » More
|
|
The effectiveness of new drugs compared with that of older drugs has fallen since the 1970s, according to a new study in Health Affairs. » More
|
|
|
Like
Tweet
